Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43()

por Blanchard, Elisabeth G., Miao, Congrong, Haupt, Thomas E., Anderson, Larry J., Haynes, Lia M.
Publicado 2011

Less common etiologies of exocrine pancreatic insufficiency

por Singh, Vikesh K, Haupt, Mark E, Geller, David E, Hall, Jerry A, Quintana Diez, Pedro M
Publicado 2017

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy

por Lindsay, Adam D., Haupt, Edward E., Chan, Chung M., Spiguel, Andre R., Scarborough, Mark T., Zlotecki, Robert A., Gibbs, Parker C.
Publicado 2018

Second Human Case of Cache Valley Virus Disease

por Campbell, Grant L., Mataczynski, James D., Reisdorf, Erik S., Powell, James W., Martin, Denise A., Lambert, Amy J., Haupt, Thomas E., Davis, Jeffrey P., Lanciotti, Robert S.
Publicado 2006

Public Health Surveillance and Reporting for Human Toxoplasmosis — Six States, 2021

por McCall, Jayden, Rothfeldt, Laura, Giesbrecht, Kelly, Hunt, Amanda, Bauck, Leah, Scheftel, Joni, Birn, Rachael, Buss, Bryan, Schroeder, Betsy, Haupt, Thomas E., Klos, Rachel, Straily, Anne
Publicado 2022

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants

por Logue, James, Johnson, Robert M., Patel, Nita, Zhou, Bin, Maciejewski, Sonia, Foreman, Bryant, Zhou, Haixia, Portnoff, Alyse D., Tian, Jing-Hui, Rehman, Asma, McGrath, Marisa E., Haupt, Robert E., Weston, Stuart M., Baracco, Lauren, Hammond, Holly, Guebre-Xabier, Mimi, Dillen, Carly, Madhangi, M., Greene, Ann M., Massare, Michael J., Glenn, Greg M., Smith, Gale, Frieman, Matthew B.
Publicado 2023

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

por Keech, Cheryl, Albert, Gary, Cho, Iksung, Robertson, Andreana, Reed, Patricia, Neal, Susan, Plested, Joyce S., Zhu, Mingzhu, Cloney-Clark, Shane, Zhou, Haixia, Smith, Gale, Patel, Nita, Frieman, Matthew B., Haupt, Robert E., Logue, James, McGrath, Marisa, Weston, Stuart, Piedra, Pedro A., Desai, Chinar, Callahan, Kathleen, Lewis, Maggie, Price-Abbott, Patricia, Formica, Neil, Shinde, Vivek, Fries, Louis, Lickliter, Jason D., Griffin, Paul, Wilkinson, Bethanie, Glenn, Gregory M.
Publicado 2020

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

por Boras, Britton, Jones, Rhys M., Anson, Brandon J., Arenson, Dan, Aschenbrenner, Lisa, Bakowski, Malina A., Beutler, Nathan, Binder, Joseph, Chen, Emily, Eng, Heather, Hammond, Holly, Hammond, Jennifer, Haupt, Robert E., Hoffman, Robert, Kadar, Eugene P., Kania, Rob, Kimoto, Emi, Kirkpatrick, Melanie G., Lanyon, Lorraine, Lendy, Emma K., Lillis, Jonathan R., Logue, James, Luthra, Suman A., Ma, Chunlong, Mason, Stephen W., McGrath, Marisa E., Noell, Stephen, Obach, R. Scott, O’ Brien, Matthew N., O’Connor, Rebecca, Ogilvie, Kevin, Owen, Dafydd, Pettersson, Martin, Reese, Matthew R., Rogers, Thomas F., Rosales, Romel, Rossulek, Michelle I., Sathish, Jean G., Shirai, Norimitsu, Steppan, Claire, Ticehurst, Martyn, Updyke, Lawrence W., Weston, Stuart, Zhu, Yuao, White, Kris M., García-Sastre, Adolfo, Wang, Jun, Chatterjee, Arnab K., Mesecar, Andrew D., Frieman, Matthew B., Anderson, Annaliesa S., Allerton, Charlotte
Publicado 2021